홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

5-Indolylboronic acid → 5-[6-(4-Cyclopropylpiperazin-1-yl)pyridazin-3-yl]-1H-indole, dihydrochloride

HRID 80925
인쇄

반응식

HRID 80925 반응식
[Cl:1][C:2]1[N:3]=[N:4][C:5]([N:8]2[CH2:13][CH2:12][N:11]([CH:14]3[CH2:16][CH2:15]3)[CH2:10][CH2:9]2)=[CH:6][CH:7]=1.[NH:17]1[C:25]2[C:20](=[CH:21][C:22](B(O)O)=[CH:23][CH:24]=2)[CH:19]=[CH:18]1>>[ClH:1].[ClH:1].[CH:14]1([N:11]2[CH2:12][CH2:13][N:8]([C:5]3[N:4]=[N:3][C:2]([C:22]4[CH:21]=[C:20]5[C:25](=[CH:24][CH:23]=4)[NH:17][CH:18]=[CH:19]5)=[CH:7][CH:6]=3)[CH2:9][CH2:10]2)[CH2:16][CH2:15]1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 27343615-Indolylboronic acidHCID 614441503-Chloro-6-(4-cyclopropylpiperazin-1-yl)pyridazine

생성물 1

HCID 1317307835-[6-(4-Cyclopropylpiperazin-1-yl)pyridazin-3-yl]-1H-indole, dihydrochloride

실험 절차

The title compound was prepared by a similar procedure to that described in Example 68, starting from 3-chloro-6-(4-cyclopropyl-piperazin-1-yl)-pyridazine and 5-indoleboronic acid.

출처 및 근거

ORD 기록
ord-7b81841d8d4248e3bf621741afedef09
출처 데이터셋
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08846677B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트